Exemption of Customs duties on import of drug Remdesivir
SRO 558(I)/2020 is a Customs SRO dated 22 June 2020, listed by FBR as "Exemption of Customs duties on import of drug Remdesivir".
FBR publishes this SRO as scanned images, so the text below was transcribed by Qanoon Digest from the page images, with tables set out as tables. Check the official PDF before relying on any wording or figure.
Page 1
GOVERNMENT OF PAKISTAN
MINISTRY OF FINANCE, ECONOMIC AFFAIRS, REVENUE AND STATISTICS
(REVENUE DIVISION)
Islamabad, the 22nd June, 2020.
NOTIFICATION
(CUSTOMS)
S.R.O. 558(I)/2020.- In exercise of the powers conferred by section 19 of the Customs Act,1969 (IV of 1969), the Federal Government is pleased to exempt the import of finished drug Remdesivir 100mg Injection and injectable solution 100mg vial (PCT 3004.9099) from whole of the customs duty and additional customs duty.
[C. No. 1(1)Tar-1/95-Pt-IV]
(S.M. Tariq Huda)
Additional Secretary
Related Customs SROs on exemptions and concessions
- SRO 1042(I)/202013 October 2020Exemption of Additional Customs Duty
- SRO 1043(I)/202013 October 2020Exemption from Regulatory Duty
- SRO 616(I)/202013 July 2020Waiver of Panel Surcharges
- SRO 593(I)/20201 July 2020Exemption of Customs duty on import of oxygen and oxygen cylinders
- SRO 556(I)202019 June 2020Exemption of Customs duty on import of COVID-19 related items
- SRO 235(I)/202020 March 2020Exemption of Customs duty, Regulatory duty and additional Customs duty on medical and testing equipment regarding out-break of COVID-19